Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
Clinical trial NCT02625935 · COMPLETED
Trial details
- NCT number
- NCT02625935
- Sponsor
- NanoString Technologies, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-06-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.